HIV

HHS Pays For PrEP But Who Will Prescribe It?
Forbes
Sat, 12/7/19 - 11:51 pm
HHS
HIV
PrEP
Ready Set PrEP
ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir
Pharmaforum
Fri, 12/6/19 - 10:02 am
ViiV Healthcare
HIV
fostemsavir
FDA
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Stat
Fri, 12/6/19 - 09:52 am
Gilead Sciences
patents
HIV
activists
TAF
Gilead’s converting Truvada PrEP users to Descovy faster than expected: analyst
Fierce Pharma
Tue, 12/3/19 - 10:31 pm
Gilead Sciences
HIV
PrEP
Truvada
Descovy
ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment
Pharmaceutical Business Review
Fri, 11/22/19 - 10:02 am
HIV
NIH
ViiV Healthcare
HIV-1
drug discovery
Will Its HIV Lineup Save Gilead Sciences?
Motley Fool
Mon, 11/11/19 - 07:50 pm
Gilead Sciences
HIV
Descovy
Biktarvy
HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills
Stat
Thu, 11/7/19 - 10:29 am
Gilead Sciences
HIV
HHS
Truvada
Descovy
FDA Gives Nod for Breakthrough HIV Test
Medical Devices and Diagnostics Industry
Tue, 11/5/19 - 11:52 pm
Vela Diagnostics
HIV
diagnostics
FDA
Sentosa SQ HIV Genotyping Assay
NIH, Gates Foundation commit $200M to cure HIV, sickle cell
Fierce Biotech
Thu, 10/24/19 - 10:18 am
NIH
Gates Foundation
HIV
sickle cell disease
GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors
Fierce Pharma
Wed, 10/9/19 - 09:49 am
GSK
ViiV Healthcare
Dovato
DTC ads
HIV
Johnson & Johnson commits $500 million over four years to help end HIV, TB epidemics
Marketwatch
Fri, 10/4/19 - 10:29 am
JNJ
Janssen
tuberculosis
HIV
philanthropy
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Thu, 10/3/19 - 10:21 pm
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
Wed, 09/25/19 - 09:16 am
GSK
ViiV
Tivicay
HIV
HemoShear
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
Fri, 09/20/19 - 09:44 am
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
HIV-focused Gilead launches fund, pledges $2M to help transgender people
Fierce Pharma
Thu, 09/12/19 - 10:34 pm
Gilead Sciences
HIV
transgender
philanthropy
CRISPR Gene-Editing May Offer Path To Cure For HIV, First Published Report Shows
NPR
Wed, 09/11/19 - 11:42 pm
HIV
CRISPR
gene editing
GSK's ViiV reports positive data for long-acting two-drug HIV therapy
Biopharma Dive
Thu, 08/22/19 - 11:46 am
ViiV Healthcare
GSK
HIV
cabotegravir
rilpivirine
Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Forbes
Mon, 08/12/19 - 10:28 am
HIV
Public Health
antiretrovirals
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Fri, 08/9/19 - 07:42 pm
Roche
viral assays
HIV
HPV
diagnostics
Global Access Program
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
Thu, 08/8/19 - 12:56 pm
FDA
Gilead Sciences
HIV
Descovy
PrEP

Pages